People aren't very happy with Mylan's EpiPen pricing strategy right now. But we think the implementation is to blame, not the prices themselves. Here's why.
Mylan's Prices Weren’t the Problem. Its Implementation Strategy Was.
Posted by TheKiniGroup under FinanceFrom https://thekinigroup.com 2802 days ago
Who Voted for this Story
Subscribe
“Rachel: Great to hear! Thanks for your kind words! :)
All the Best,
Martin...”
“Thank you, Martin. That's a fantastic motto... and I couldn't agree more!...”
“Lisa: Good to hear! Thanks for your response....”
“For sure, I know I did years ago when I was working for others....”
“Lisa: I wonder if they potential employee is doing a background check on...”
Comments